{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:44:53Z","timestamp":1776876293731,"version":"3.51.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T00:00:00Z","timestamp":1132012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"},{"start":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T00:00:00Z","timestamp":1132012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hered Cancer Clin Pract"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A germline mutation in the Von-Hippel Lindau (VHL) gene predisposes carriers to development of abundantly vascularised tumours in the retina, cerebellum, spine, kidney, adrenal gland and pancreas. Most VHL patients die from the consequences of cerebellar haemangioblastoma or renal cell carcinoma. The VHL gene is a tumour suppressor gene and is involved in angiogenesis by regulation of the activity of hypoxia-inducible factor 1-\u03b1 (HIF1-\u03b1). Clinical diagnosis of VHL can be confirmed by molecular genetic analysis of the VHL gene, which is informative in virtually all VHL families. A patient with (suspicion for) VHL is an indication for genetic counselling and periodical examination.<\/jats:p>","DOI":"10.1186\/1897-4287-3-4-171","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T02:08:20Z","timestamp":1341454100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Von Hippel-Lindau Disease"],"prefix":"10.1186","volume":"3","author":[{"given":"Frederik J","family":"Hes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo WM","family":"H\u00f6ppener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob B van der","family":"Luijt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis JM","family":"Lips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,15]]},"reference":[{"issue":"9374","key":"58_CR1","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH: von Hippel-Lindau disease. Lancet 2003,361(9374):2059\u20132067. 10.1016\/S0140-6736(03)13643-4","journal-title":"Lancet"},{"issue":"24","key":"58_CR2","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa040666","volume":"350","author":"RR Lonser","year":"2004","unstructured":"Lonser RR, Kim HJ, Butman JA, Vortmeyer AO, Choo DI, Oldfield EH: Tumours of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med 2004,350(24):2481\u20132486. 10.1056\/NEJMoa040666","journal-title":"N Engl J Med"},{"key":"58_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/00005792-199711000-00001","volume":"76","author":"ER Maher","year":"1997","unstructured":"Maher ER, Kaelin WG Jr: von Hippel-Lindau disease. Medicine (Baltimore) 1997, 76: 381\u2013391. 10.1097\/00005792-199711000-00001","journal-title":"Medicine (Baltimore)"},{"key":"58_CR4","volume-title":"Von Hippel-Lindau disease: clinical and genetic investigations in the Netherlands","author":"F Hes","year":"2000","unstructured":"Hes F: Von Hippel-Lindau disease: clinical and genetic investigations in the Netherlands. Utrecht University, thesis; 2000."},{"issue":"6","key":"58_CR5","first-page":"547","volume":"243","author":"S Richard","year":"1998","unstructured":"Richard S, Campello C, Taillandier L, Parker F, Resche F: Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group. J Intern Med 1998,243(6):547\u2013553.","journal-title":"French VHL Study Group. J Intern Med"},{"issue":"5112","key":"58_CR6","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou FW, Li H, Wei MH, Chen F, Glenn GM, Choyke PL, Walther MM, Weng Y, Duan DR, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson Smith MA, Paslier lD, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI: Identification of the von Hippel-Lindau disease tumour suppressor gene. Science 1993,260(5112):1317\u20131320. 10.1126\/science.8493574","journal-title":"Science"},{"issue":"4","key":"58_CR7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson","year":"1971","unstructured":"Knudson AG: Mutation and cancer: Statistical study of Retinoblastoma. Proc Natl Acad Sci USA 1971,68(4):820\u2013823. 10.1073\/pnas.68.4.820","journal-title":"Proc Natl Acad Sci USA"},{"key":"58_CR8","first-page":"231","volume":"75","author":"M Los","year":"1996","unstructured":"Los M, Jansen GH, Kaelin WG Jr, Lips CJM, Blijham GH, Voest EE: Expression Pattern of the von Hippel-Lindau Protein in Human Tissues. Lab Invest 1996, 75: 231\u2013238.","journal-title":"Lab Invest"},{"issue":"5","key":"58_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/hmg\/5.5.639","volume":"5","author":"FM Richards","year":"1996","unstructured":"Richards FM, Schofield PN, Fleming S, Maher ER: Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis. Hum Mol Genet 1996,5(5):639\u2013644. 10.1093\/hmg\/5.5.639","journal-title":"Hum Mol Genet"},{"issue":"6733","key":"58_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999,399(6733):271\u2013275. 10.1038\/20459","journal-title":"Nature"},{"issue":"17","key":"58_CR11","first-page":"4440","volume":"59","author":"M Los","year":"1999","unstructured":"Los M, Zeamari S, Foekens JA, Gebbink MF, Voest EE: Regulation of the urokinase-type plasminogen activator system by the von Hippel-Lindau tumour suppressor gene. Cancer Res 1999,59(17):4440\u20134445.","journal-title":"Cancer Res"},{"issue":"3","key":"58_CR12","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1078-0432.1059.11.3","volume":"11","author":"YS Lee","year":"2005","unstructured":"Lee YS, Vortmeyer AO, Lubensky IA, Vogel TW, Ikejiri B, Ferlicot S, Benoit G, Giraud S, Oldfield EH, Linehan WM, Teh BT, Richard S, Zhuang Z: Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma. Clin Cancer Res 2005,11(3):1059\u201364.","journal-title":"Clin Cancer Res"},{"issue":"5413","key":"58_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.284.5413.455","volume":"284","author":"CE Stebbins","year":"1999","unstructured":"Stebbins CE, Kaelin WG Jr, Pavletich NP: Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumour suppressor function. Science 1999,284(5413):455\u2013461. 10.1126\/science.284.5413.455","journal-title":"Science"},{"issue":"10","key":"58_CR14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","volume":"10","author":"MA Hoffman","year":"2001","unstructured":"Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, Kaelin WG Jr: von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hum Mol Genet 2001,10(10):1019\u20131027. 10.1093\/hmg\/10.10.1019","journal-title":"Hum Mol Genet"},{"issue":"4","key":"58_CR15","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1086\/302037","volume":"63","author":"AR Webster","year":"1998","unstructured":"Webster AR, Richards FM, MacRonald FE, Moore AT, Maher ER: An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects. Am J Hum Genet 1998,63(4):1025\u20131035. 10.1086\/302037","journal-title":"Am J Hum Genet"},{"issue":"3","key":"58_CR16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1210\/jc.2002-021466","volume":"88","author":"FJ Hes","year":"2003","unstructured":"Hes FJ, H\u00f6ppener JW, Lips CJ: Clinical review 155: Pheochromocytoma in Von Hippel-Lindau disease. J Clin Endocrinol Metab 2003,88(3):969\u2013974. 10.1210\/jc.2002-021466","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"58_CR17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","volume":"12","author":"C Stolle","year":"1998","unstructured":"Stolle C, Glenn G, Zbar B, Humphrey JS, Choyke P, Walther M, Pack S, Hurley K, Andrey C, Klausner R, Linehan WM: Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 1998,12(6):417\u2013423. 10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","journal-title":"Hum Mutat"},{"issue":"12","key":"58_CR18","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1210\/jc.82.12.4101","volume":"82","author":"H Brauch","year":"1997","unstructured":"Brauch H, Hoeppner W, Jahnig H, Wohl T, Engelhardt D, Spelsberg F, Ritter MM: Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene. J Clin Endocrinol Metab 1997,82(12):4101\u20134104. 10.1210\/jc.82.12.4101","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"58_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<337::AID-IJC5>3.0.CO;2-P","volume":"77","author":"Evan der Harst","year":"1998","unstructured":"Harst E, de Krijger RR, Dinjens WN, Weeks LE, Bonjer HJ, Bruining HA, Lamberts SW, Koper JW: Germline mutations in the vhl gene in patients presenting with phaeochromocytomas. Int J Cancer 1998,77(3):337\u2013340. 10.1002\/(SICI)1097-0215(19980729)77:3<337::AID-IJC5>3.0.CO;2-P","journal-title":"Int J Cancer"},{"issue":"4","key":"58_CR20","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/S0022-5347(01)62509-6","volume":"160","author":"HP Neumann","year":"1998","unstructured":"Neumann HP, Bender BU, Berger DP, Laubenberger J, Schultze-Seemann W, Wetterauer U, Ferstl FJ, Herbst EW, Schwarzkopf G, Hes FJ, Lips CJ, Lamiell JM, Masek O, Riegler P, Mueller B, Glavac D, Brauch H: Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 1998,160(4):1248\u20131254. 10.1016\/S0022-5347(01)62509-6","journal-title":"J Urol"},{"key":"58_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1136\/jmg.37.12.939","volume":"37","author":"FJ Hes","year":"2000","unstructured":"Hes FJ, McKee S, Taphoorn MJB, Rehal P, Luijt RB, McMahon R, Smagt JJ, Dow D, Zewald RA, Whittaker J, Lips CJM, MacDonald F, Pearson PL, Maher ER: Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only. J Med Genet 2000, 37: 939\u2013943. 10.1136\/jmg.37.12.939","journal-title":"J Med Genet"},{"issue":"1","key":"58_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<86::AID-HUMU16>3.0.CO;2-4","volume":"15","author":"C Beroud","year":"2000","unstructured":"Beroud C, Collod-Beroud G, Boileau C, Soussi T, Junien C: UMD (Universal mutation database): a generic software to build and analyze locus-specific databases. Hum Mutat 2000,15(1):86\u201394. 10.1002\/(SICI)1098-1004(200001)15:1<86::AID-HUMU16>3.0.CO;2-4","journal-title":"Hum Mutat"},{"issue":"11","key":"58_CR23","first-page":"505","volume":"144","author":"FJ Hes","year":"2000","unstructured":"Hes FJ, Luijt RB: [Von Hippel-Lindau disease: protocols for diagnosis and periodical clinical monitoring. National Von Hippel-Lindau Disease Working Group]. Ned Tijdschr Geneeskd 2000,144(11):505\u201350.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"1","key":"58_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1046\/j.1365-2362.1999.00402.x","volume":"29","author":"FJ Hes","year":"1999","unstructured":"Hes FJ, Slootweg PJ, van Vroonhoven TJ, Hene RJ, Feldberg MA, Zewald RA, van Amstel JK, Hoppener JW, Pearson PL, Lips CJ: Management of renal cell carcinoma in von Hippel-Lindau disease. Eur J Clin Invest 1999,29(1):68\u201375. 10.1046\/j.1365-2362.1999.00402.x","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"58_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3171\/jns.2003.98.1.0082","volume":"98","author":"JE Wanebo","year":"2003","unstructured":"Wanebo JE, Lonser RR, Glenn GM, Oldfield EH: The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 2003,98(1):82\u201394. 10.3171\/jns.2003.98.1.0082","journal-title":"J Neurosurg"},{"key":"58_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3171\/jns.2005.102.s_supplement.0171","volume":"102","author":"M Tago","year":"2005","unstructured":"Tago M, Terahara A, Shin M, Maruyama K, Kurita H, Nakagawa K, Ohtomo K: Gamma knife surgery for hemangioblastomas. J Neurosurg 2005, 102: 171\u2013174. 10.3171\/jns.2005.102.s_supplement.0171","journal-title":"J Neurosurg"},{"issue":"9486","key":"58_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"Lenders JW, Eisenhofer G, Mannelli M, Pacak K: Phaeochromocytoma. Lancet 2005,366(9486):665\u2013675. 10.1016\/S0140-6736(05)67139-5","journal-title":"Lancet"}],"container-title":["Hereditary Cancer in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1897-4287-3-4-171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1897-4287-3-4-171\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1897-4287-3-4-171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T02:06:48Z","timestamp":1687572408000},"score":1,"resource":{"primary":{"URL":"https:\/\/hccpjournal.biomedcentral.com\/articles\/10.1186\/1897-4287-3-4-171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,15]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["58"],"URL":"https:\/\/doi.org\/10.1186\/1897-4287-3-4-171","relation":{},"ISSN":["1897-4287"],"issn-type":[{"value":"1897-4287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,15]]},"assertion":[{"value":"5 November 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"171"}}